Industry & Business

Shire to expand biotechnology manufacturing capacity in Ireland

 Breaking News
  • Mazars Unveils New Galway Office Leading audit, tax and advisory firm Mazars has officially opened its new Galway office and announced that it will create up to 30 new jobs over a three-year period, doubling the headcount of the office from 30 to 60. While 20 of the new positions will service its recently created outsourced accounting business in Galway, [...]...
  • Ireland Leads in Fight For Manufacturing Jobs For Now These are good days for Ireland’s manufacturers as a resurgent economy driven by home-grown and foreign investment provide the biggest turnaround since the financial collapse 10 years ago, writes John Whelan. Irish manufacturing firms recorded the highest increase in industrial production across all EU countries in the year to August 2018, according to new Eurostat figures. The rate [...]...
  • Engineering Business Camlin to Create Almost 300 Jobs in £28 Million Investment Engineering business, Camlin is creating 298 high value jobs as part of a £28 million expansion at its Lisburn headquarters. Camlin develops and supplies innovative engineering solutions, primarily for the electricity and rail industries. Speaking at the official opening of its new state-of-the-art factory, Invest Northern Ireland Chief Executive, Alastair Hamilton said: “Camlin is a high-tech [...]...
  • Ireland’s Nation Brand Booming – Brand Finance Report Ireland’s nation brand continues to be one of the fastest-growing in the world, rising 26% in value year on year to US$538 billion, according to the latest Brand Finance Nation Brands report. Jumping six places in the ranking, Ireland has broken into the top 30, growing faster than the USA, China or the UK. This [...]...
  • MSD Announces New Manufacturing Facility and 170 New Jobs For Carlow MSD, known as Merck in the US and Canada, has announced that it will construct a second manufacturing facility at its existing site in Carlow with the creation of 170 new jobs. The new facility will focus on the production of vaccines and biologics and is scheduled to commence manufacturing operations in 2023. The build will include an [...]...

Shire to expand biotechnology manufacturing capacity in Ireland

April 15
14:17 2016

imagesShire plc (LSE: SHP, NASDAQ: SHPG) announces that it plans to expand its global biotechnology manufacturing capacity over the next four years by investing US$400 million in Ireland to meet the rapidly growing demand for its highly innovative products and robust pipeline.

Shire will create a new, state of the art biologics manufacturing campus, which it expects will lead to the creation of approximately 400 permanent jobs on a 120 acre site at Piercetown, County Meath. Construction of the new site will begin in mid-2016 with the site expected to be operational by mid-2019.

“Increasing our biologics manufacturing capability is fundamental to achieving our ambition of becoming the world’s leading Biotechnology Company focused on rare diseases and other speciality conditions. The expansion will enable us to meet increasing product demands, support our pipeline and, ultimately, help more patients. We are delighted to be expanding our operations in Ireland, where we have strong, existing relationships. The new campus in County Meath will provide necessary geographic diversification and will help us serve our growing international business.”Shire’s Chief Executive Officer, Flemming Ornskov, MD, MPH, 

Employing the latest bioprocessing techniques, the facility will employ flexible production strategies enabling it to supply both clinical and commercial scale products. The roles at Shire’s new campus in County Meath will consist of highly skilled, full time jobs in the areas of R&D, operations, technical staff, engineering and construction.

Shire’s Senior Vice President of Technical Operations, Tim Kelly, commented “The expansion supports our manufacturing strategy to develop and provide innovative specialty medicines for patients. Ireland is a strategically important location for Shire, providing both excellence in life science R&D and manufacturing. We already have a strong team on the ground in Ireland and believe that it is the right location for us to build a new state of the art facility which will complement our existing manufacturing operations in the US.”

Mr. Richard Bruton TD, Irish Minister for Jobs, Enterprise and Innovation, said “Today’s announcement is a huge boost for the Irish economy and for County Meath. The scale of the global investment being made by Shire and the creation of 400 full-time positions in Ireland, as well as over 700 additional jobs during construction, will have a major impact,  and further validates Ireland’s position as a leading global location for biotechnology manufacturing and R&D. Biotechnology is a key sector which we have targeted as part of our jobs plans, and Shire’s decision to build on its very capable team already in Ireland with a $400million investment is a very welcome step-up in its presence here.”

About Author

admin

admin

Related Articles

New Subscriber





Subscribe Here



Advertisements



















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4